Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2022-02-28

Clinical Trial Update: Beneficial Impact of Orange Juice Consumption on Risk Factors Associated With Cardiovascular Diseases [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the beneficial impact of orange juice consumption on risk factors associated with cardiovascular diseases has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Technological Centre of Nutrition and Health, Spain | Conditions: Cardiovascular Risk Factors | Phase 3 | Status: COMPLETED